Lenar Aimee J.
CIK 2029927 · EVP, US Pharma · last filed 2026-02-27
Lenar Aimee J. is an EVP, US Pharma who has filed 5 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for BHC, was dated Feb 27, 2026. Current disclosed insider exposure totals $2.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.07M
1
5
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BHC | EVP, US Pharma | 400,335 | $5.17 | $2.07M | $0 | 5 | 2026-02-27 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-27 | BHC | Mixed | +139,561 | -$106.2K | EDGAR |
| 2025-07-18 | BHC | Grant (A) | +30,847 | $0 | EDGAR |
| 2025-07-16 | BHC | Tax (F) | −22,736 | -$146.0K | EDGAR |
| 2025-02-28 | BHC | Grant (A) | +108,311 | $0 | EDGAR |
| 2024-07-17 | BHC | Grant (A) | +144,352 | $0 | EDGAR |